财务表现 - 基础设施分部DBM Global第二季度收入为3.052亿美元，同比下降15.8%[10] - DBM Global毛利率扩大至20.2%，同比增加约650个基点，调整后EBITDA率扩大至10.6%，同比增加约420个基点[12] - 第二季度总Adjusted EBITDA为2670万美元，较上年同期的1650万美元增加[26] - Infrastructure分部Adjusted EBITDA为3250万美元，较上年同期增加900万美元[26] - Life Sciences分部Adjusted EBITDA为-480万美元，较上年同期减少90万美元[26] - Spectrum分部Adjusted EBITDA为150万美元，较上年同期增加70万美元[26] - 2024年第二季度基础设施分部调整后EBITDA为32.5百万美元，2023年同期为23.5百万美元[49][51] - 2024年上半年基础设施分部调整后EBITDA为50.8百万美元，2023年同期为23.5百万美元[53][54] - 基础设施分部净收入为9.0亿美元[55] - 生命科学分部净亏损为5.7亿美元[55] - 非经营性公司分部净亏损为20.1亿美元[55] - 折旧和摊销费用为11.9亿美元[55] - 利息费用为31.9亿美元[55] - 其他收益净额为16.8亿美元[55] - 调整后EBITDA为21.4亿美元[55] - 基础设施分部调整后EBITDA为39.8亿美元[55] - 生命科学分部调整后EBITDA为11.7亿美元亏损[55] - 非经营性公司分部调整后EBITDA为6.9亿美元亏损[55] 业务表现 - DBM Global的报告在手订单和调整后在手订单分别为0.8亿美元和10亿美元[12] - 生命科学分部R2在北美创下冰川系统销售新纪录，患者治疗量和每个账户的平均使用量均创新高[13][14] - 广播分部推出了第三个网络Defy，并在全美60%的地区提供广播分销[16] - 广播分部第二季度收入为620万美元，同比增长8.8%，调整后EBITDA为150万美元，同比增加87.5%[19] 财务状况 - 2024年6月30日现金及现金等价物为8020万美元，较2023年12月31日的8080万美元减少[29] - 非运营公司分部2024年6月30日现金及现金等价物为4360万美元，较2023年12月31日的250万美元增加[29] - 2024年6月30日现金及现金等价物为80.2百万美元，2023年12月31日为80.8百万美元[46] - 2024年6月30日总资产为898.9百万美元，2023年12月31日为1043.6百万美元[46] - 2024年6月30日总负债为1009.1百万美元，2023年12月31日为1179.9百万美元[46] 其他 - 公司将于2024年8月20日举行第二季度财报电话会议[30][31][32][33] - 基本加权平均普通股数为8920.485万股，稀释后为14425.7552万股[45]

- Infrastructure: DBM Global achieved second quarter revenue of $305.2 million - - Life Sciences: R2 achieved record Glacial system sales in North America in the second quarter - - Spectrum: Broadcasting's growth driven by launch of new networks and cost-cutting efforts - NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE: VATE) announced today its consolidated results for the second quarter. Financial Summary | --- | --- | --- | --- | --- | --- | --- | --- | --- ...

As a result of the reverse stock split, every ten shares of the Company's Common Stock issued and outstanding will be automatically reclassified and changed into one new share of the Company's Common Stock. Proportionate adjustments will be made to the exercise prices and the number of shares underlying the Company's outstanding equity awards, as applicable, as well as to the number of shares issuable under the Company's equity incentive plans and conversion of the Company's outstanding convertible securiti ...

NEW YORK, July 29, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE: VATE), a diversified holding company, announced today that the Company is amending the effective date for its 1-for-10 reverse stock split of the Company's common stock, par value $0.001 per share (the "Common Stock"). The reverse stock split will become effective at 5:00 p.m. Eastern Time on August 8, 2024, after close of trading on the New York Stock Exchange. Previously, the Company planned for the reverse sto ...

Computershare, Inc. ("Computershare"), the Company's transfer agent, is acting as the exchange agent for the Reverse Stock Split. Stockholders holding their shares electronically in book-entry form will not need to take any action. Stockholders holding certificated shares will be required to turn in their existing certificates, and all new shares will be issued in book-entry form, unless such stockholder requests otherwise. NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Compa ...

The primary goal of the reverse stock split is to increase the per share market price of the Company's Common Stock to meet the minimum per share bid price requirement for continued listing on the NYSE. The reverse stock split was approved by the Company's stockholders at its annual meeting of stockholders held on June 18, 2024. Computershare, Inc. ("Computershare"), the Company's transfer agent, is acting as the exchange agent for the Reverse Stock Split. Stockholders holding their shares electronically in ...

About INNOVATE Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE's Investor Relations website at www.innovate-ir.com. To listen to the live call, please go to the "Investor Relations" section of the Company's website at least 15 minutes prior to the start of the call to register and download any necessary audio software. For those who are not able to ...

财务数据和关键指标变化 - 公司实现收入3.152亿美元,同比下降0.8% [24] - 归属普通股东净亏损1770万美元,每股亏损0.22美元,同比增加 [25] - 调整后EBITDA1280万美元,同比增长 [26] 各条业务线数据和关键指标变化 基础设施业务 - 收入3.079亿美元,同比下降1.2% [26] - 调整后EBITDA1830万美元,同比增长 [27] - 在手订单939.1百万美元,调整后在手订单12亿美元 [28] - 债务减少3910万美元,过去6个月减少7300万美元 [29] 生命科学业务 - 收入100万美元,同比增长50% [30] - 调整后EBITDA亏损减少,主要由于MediBeacon投资亏损减少和R2费用下降 [30] 频谱业务 - 收入6300万美元,同比增长9.5% [31] - 调整后EBITDA160万美元,同比增长 [32] 公司战略和发展方向及行业竞争 - 基础设施业务在工业和模块化领域有众多机会,将成为未来重要业务 [9] - 生命科学业务R2在北美系统销售增长183%,在中东地区也有新的发展 [10][11] - MediBeacon肾功能监测项目正在与FDA互动解决问题,以推进审批 [13][14] - 频谱业务新网络推出带动收入增长,并探索5G广播等新技术机会 [17][19] 管理层对经营环境和未来前景的评论 - 基础设施业务市场环境仍然紧张,但新项目活动旺盛 [9] - 生命科学业务R2增长势头良好,MediBeacon有望获批 [10][11][13][14] - 频谱业务新网络推出和新技术探索为未来带来机遇 [17][19] - 公司正在采取措施优化资本结构,为未来发展创造条件 [20][21][22] 其他重要信息 - 公司未能符合纽交所最低股价要求,正在采取措施如反向拆股等来恢复合规 [35] - 公司总债务6.87亿美元,较年末下降3580万美元 [36]

INNOVATE Corp. Q1 2024 Earnings Release Supplement INNOVATE Corp. ™ 2024 Cautionary Statement Regarding Forward-Looking Statements The Company believes these judgments are reasonable, but these statements are not guarantees of performance, results or the creation of stockholder value and the Company's actual results could differ materially from those expressed or implied in the forward-looking statements due to a variety of important factors, both positive and negative, including those that may be identifie ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 54-1708481 (State or other jurisdiction of (I.R.S. Employer incorporation or organization ...